Comparison of plasma and CSF biomarkers in predicting cognitive decline

OBJECTIVES: Concentrations of amyloid‐β peptides (Aβ42/Aβ40) and neurofilament light (NfL) can be measured in plasma or cerebrospinal fluid (CSF) and are associated with Alzheimer’s disease brain pathology and cognitive impairment. This study directly compared plasma and CSF measures of Aβ42/Aβ40 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Aschenbrenner, Andrew J., Li, Yan, Henson, Rachel L., Volluz, Katherine, Hassenstab, Jason, Verghese, Philip, West, Tim, Meyer, Matthew R., Kirmess, Kristopher M., Fagan, Anne M., Xiong, Chengjie, Holtzman, David, Morris, John C., Bateman, Randall J., Schindler, Suzanne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639639/
https://www.ncbi.nlm.nih.gov/pubmed/36183195
http://dx.doi.org/10.1002/acn3.51670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639639/
https://www.ncbi.nlm.nih.gov/pubmed/36183195
http://dx.doi.org/10.1002/acn3.51670

Ejemplares similares